Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

Britain to offer COVID vaccines to all 5-11 year olds

Published 16/02/2022, 11:38
© Reuters. FILE PHOTO: A person wearing a face mask shops in London, Britain, November 30, 2021. REUTERS/Hannah McKay

By Alistair Smout

LONDON (Reuters) -Britain said on Wednesday it would offer COVID-19 vaccines to all 5-11 year olds, widening the rollout of vaccines in children in a decision that has been taken more slowly than in some other countries.

Announcing the move, health minister Sajid Javid said he had accepted advice from experts who argued that vaccinating young children would help protect against future waves of the coronavirus.

Britain has offered COVID-19 shots to vulnerable children, but has been slower than the likes of the United States, Canada, Ireland and Israel in making a broad offer of shots to all 5- to 11-year-olds.

The Joint Committee on Vaccination and Immunisation (JCVI) said that shots for the cohort would help increase protection against severe illness in children should there be future waves of COVID-19.

Javid said the government accepted the advice for England, and preparations for the rollout were under way within the National Health Service (NHS).

"The NHS will prepare to extend this non-urgent offer to all children during April," he said. "So parents can, if they want, take up the offer to increase protection against potential future waves of COVID-19 as we learn to live with this virus."

The British government will set out further detail of its plan for living with COVID on Monday.

The JCVI said that there was a non-urgent offer of the Pfizer (NYSE:PFE) BioNTech paediatric COVID vaccine for the age group, with at least 12 weeks between doses.

All four nations of the United Kingdom have followed JCVI guidance on the rollout of COVID-19 vaccines. Scotland and Wales had already said it would accept JCVI advice in favour of vaccination for children aged 5-11.

Britain has reported 160,000 deaths from COVID-19, and while it has moved quickly to vaccinate the elderly and most vulnerable, it has taken a more cautious approach on COVID shots for children.

© Reuters. FILE PHOTO: Deputy charge nurse Katie McIntosh waits to administer the first of two Pfizer/BioNTech COVID-19 vaccine jabs to the staff, at the Western General Hospital, on the first day of the largest immunisation programme in the British history, in Edinburgh, Scotland Britain December 8, 2020. Andrew Milligan/Pool via REUTERS/File Photo

Peter English, a retired consultant in Communicable Disease Control said that while deaths from COVID in children were rare, vaccines were important for minimising long COVID or severe outcomes in children, adding that the shots were safe.

"Many other countries have been vaccinating children aged 5 upwards for months now; the evidence of safety is overwhelming," English said. "The UK has been dragging its feet on this issue."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.